Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$1.53B |
| 2 |
Procter & Gamble
PG
|
+$1.01B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$684M |
| 4 |
Zoom
ZM
|
+$534M |
| 5 |
Chewy
CHWY
|
+$491M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.07B |
| 2 |
ServiceNow
NOW
|
+$874M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$776M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$767M |
| 5 |
Apple
AAPL
|
+$719M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.32% |
| 2 | Healthcare | 10.4% |
| 3 | Consumer Discretionary | 8.1% |
| 4 | Communication Services | 7.82% |
| 5 | Financials | 7.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MODN
3226
DELISTED
MODEL N, INC.
MODN
| $2.71M | ﹤0.01% |
77,989
-285,793
| -79% | -$8.33M |
|
3227
StoneX
SNEX
$8.07B
| $2.71M | ﹤0.01% |
249,171
+7,249
| +3% | +$62.9K |
|
3228
Cemex
CX
$16.3B
| $2.71M | ﹤0.01% |
940,133
+372,589
| +66% | +$874K |
|
|
PFN
3229
PIMCO Income Strategy Fund II
PFN
$702M
| $2.71M | ﹤0.01% |
310,876
-136,245
| -30% | -$1.12M |
|
|
PDT
3230
John Hancock Premium Dividend Fund
PDT
$622M
| $2.71M | ﹤0.01% |
203,370
-11,824
| -5% | -$153K |
|
3231
Ameresco
AMRC
$1.36B
| $2.7M | ﹤0.01% |
97,326
+12,038
| +14% | +$243K |
|
3232
Pathward Financial
CASH
$1.86B
| $2.7M | ﹤0.01% |
148,720
-28,647
| -16% | -$502K |
|
3233
Franklin US Core Bond ETF
FLCB
$3.03B
| $2.7M | ﹤0.01% |
+102,916
| New | +$2.67M |
|
|
LGF.B
3234
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $2.69M | ﹤0.01% |
394,385
+63,794
| +19% | +$441K |
|
|
MAXR
3235
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $2.69M | ﹤0.01% |
149,900
+100,405
| +203% | +$1.3M |
|
|
LUNA
3236
DELISTED
Luna Innovations Incorporated
LUNA
| $2.69M | ﹤0.01% |
460,714
+178,373
| +63% | +$1.16M |
|
3237
Atlanta Braves Holdings Series B
BATRK
$3.13B
| $2.69M | ﹤0.01% |
136,180
+19,091
| +16% | +$379K |
|
3238
Agios Pharmaceuticals
AGIO
$1.91B
| $2.69M | ﹤0.01% |
50,256
-72,128
| -59% | -$3.34M |
|
3239
AdvanSix
ASIX
$543M
| $2.69M | ﹤0.01% |
228,812
+64,395
| +39% | +$749K |
|
3240
Stewart Information Services
STC
$2.09B
| $2.68M | ﹤0.01% |
82,480
-10,186
| -11% | -$306K |
|
3241
Benchmark Electronics
BHE
$2.96B
| $2.68M | ﹤0.01% |
124,065
-20,025
| -14% | -$420K |
|
3242
iShares MSCI Europe Small-Cap ETF
IEUS
$183M
| $2.68M | ﹤0.01% |
57,044
-103,166
| -64% | -$4.5M |
|
|
ICPT
3243
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $2.68M | ﹤0.01% |
55,869
-7,702
| -12% | -$595K |
|
3244
Invesco Advantage Municipal Income Trust II
VKI
$397M
| $2.67M | ﹤0.01% |
255,563
+11,782
| +5% | +$121K |
|
|
EVM
3245
DELISTED
Eaton Vance California Municipal Bond Fund
EVM
| $2.67M | ﹤0.01% |
239,655
+609
| +0.3% | +$6.56K |
|
|
NGHC
3246
DELISTED
National General Holdings Corp
NGHC
| $2.67M | ﹤0.01% |
123,503
-18,326
| -13% | -$345K |
|
3247
Invesco Zacks Multi-Asset Income ETF
CVY
$124M
| $2.66M | ﹤0.01% |
162,230
-44,570
| -22% | -$699K |
|
|
STON
3248
DELISTED
StoneMor Inc.
STON
| $2.66M | ﹤0.01% |
3,427,482
-435,952
| -11% | -$301K |
|
|
BMCH
3249
DELISTED
BMC Stock Holdings, Inc
BMCH
| $2.66M | ﹤0.01% |
105,947
+32,997
| +45% | +$730K |
|
3250
Mind CTI
MNDO
$20.6M
| $2.66M | ﹤0.01% |
1,267,739
+47,521
| +4% | +$87.7K |
|
Similar funds
Morgan Stanley's Q2 2020 Portfolio in Review
As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,644 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
- Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
- Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
- Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
- Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
- Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
- Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.
Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.